Related references
Note: Only part of the references are listed.Homomultimerization of mutant calreticulin is a prerequisite for MPL binding and activation
Marito Araki et al.
LEUKEMIA (2019)
Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants
Christian Pecquet et al.
BLOOD (2019)
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants
Ilyas Chachoua et al.
BLOOD (2016)
Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms
Marito Araki et al.
BLOOD (2016)
Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation
Shannon Elf et al.
CANCER DISCOVERY (2016)
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
J. Nangalia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes
Christian Pecquet et al.
BLOOD (2012)
Calreticulin: non-endoplasmic reticulum functions in physiology and disease
Leslie I. Gold et al.
FASEB JOURNAL (2010)
Janus kinases affect thrombopoietin receptor cell surface localization and stability
Y Royer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Share Paper
